Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2014 1
2015 1
2020 53
2021 37
2022 9
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 32371558

101 results

Results by year

Filters applied: . Clear all
Page 1
Hydroxychloroquine use in the COVID-19 patient.
Littlejohn E. Littlejohn E. Cleve Clin J Med. 2020 Sep 2. doi: 10.3949/ccjm.87a.ccc011. Online ahead of print. Cleve Clin J Med. 2020. PMID: 32371558 Free article.
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R, García-Otero L, Pons-Duran C, Marbán-Castro E, Goncé A, Llurba E, Gil MDM, Rodríguez-Zambrano MÁ, Chen H, Ramírez M, Bardají A, Menendez C. González R, et al. Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y. Trials. 2020. PMID: 32616063 Free PMC article.
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV, Brown E, Bershteyn A, Miller RS, Wener M, Celum C, Wald A, Chu H, Wesche D, Baeten JM; Hydroxychloroquine COVID-19 PEP Study Team. Barnabas RV, et al. Trials. 2020 Jun 3;21(1):475. doi: 10.1186/s13063-020-04446-4. Trials. 2020. PMID: 32493478 Free PMC article.
Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
Martins-Filho PR, Ferreira LC, Heimfarth L, Araújo AAS, Quintans-Júnior LJ. Martins-Filho PR, et al. Lancet Reg Health Am. 2021 Oct;2:100062. doi: 10.1016/j.lana.2021.100062. Epub 2021 Aug 29. Lancet Reg Health Am. 2021. PMID: 34485970 Free PMC article.
Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial.
Tirupakuzhi Vijayaraghavan BK, Jha V, Rajbhandari D, Myatra SN, John O, Ghosh A, Bassi A, Arfin S, Kunigari M, Joshi R, Donaldson L, Hammond N, Venkatesh B; HOPE investigators. Tirupakuzhi Vijayaraghavan BK, et al. Trials. 2020 Aug 31;21(1):754. doi: 10.1186/s13063-020-04679-3. Trials. 2020. PMID: 32867852 Free PMC article.
101 results